🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, alleging the corporations concealed alleged dangers that the pain reliever created to children's brain development.

The court filing arrives a month after Former President Trump publicized an unverified association between consuming Tylenol - also known as acetaminophen - throughout gestation and autism in offspring.

Paxton is suing the pharmaceutical giant, which previously sold the medication, the exclusive pain medication suggested for pregnant women, and the current manufacturer, which presently makes it.

In a official comment, he said they "betrayed America by profiting off of suffering and marketing drugs regardless of the risks."

Kenvue states there is no credible evidence connecting Tylenol to autism.

"These corporations deceived for years, intentionally threatening numerous people to boost earnings," the attorney general, a Republican, stated.

The company said in a statement that it was "very worried by the spread of false claims on the security of acetaminophen and the potential impact that could have on the well-being of American women and children."

On its official site, Kenvue also mentioned it had "continuously evaluated the pertinent research and there is lacking reliable evidence that shows a established connection between taking acetaminophen and autism."

Associations acting on behalf of medical professionals and healthcare providers concur.

ACOG has declared acetaminophen - the main ingredient in Tylenol - is among limited choices for women during pregnancy to address discomfort and elevated temperature, which can pose major wellness concerns if ignored.

"In multiple decades of research on the use of acetaminophen in pregnancy, zero credible investigations has definitively established that the usage of paracetamol in any stage of pregnancy results in neurological conditions in offspring," the group commented.

The lawsuit references latest statements from the former administration in arguing the drug is reportedly hazardous.

In recent weeks, Trump caused concern from medical authorities when he told women during pregnancy to "resist strongly" not to consume acetaminophen when sick.

The US Food and Drug Administration then published an announcement that medical professionals should contemplate reducing the use of acetaminophen, while also mentioning that "a direct connection" between the drug and autism in young ones has not been established.

Health Secretary Robert F Kennedy Jr, who manages the FDA, had promised in April to initiate "extensive scientific investigation" that would identify the source of autism in a matter of months.

But experts warned that identifying a unique factor of autism spectrum disorder - considered by experts to be the result of a complicated interplay of inherited and surrounding conditions - would be difficult.

Autism spectrum disorder is a type of permanent neurological difference and disability that influences how people encounter and interact with the surroundings, and is recognized using physician assessments.

In his court filing, the attorney general - who supports Trump who is campaigning for the Senate - asserts the manufacturer and J&J "willfully ignored and attempted to silence the research" around acetaminophen and autism.

The case attempts to require the corporations "remove any marketing or advertising" that states Tylenol is safe for expectant mothers.

The court case mirrors the grievances of a assembly of guardians of children with autism and ADHD who filed suit against the manufacturers of acetaminophen in 2022.

Judicial authorities threw out the legal action, stating research from the family's specialists was not conclusive.